---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-009571"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2025-03-07T23:59:59+00:00"
generated_at: "2026-05-25T04:02:53.290344+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ZyVersa raises ~$2M in private placement; special meeting adjourned without quorum

## Summary
- Gross proceeds of $2M from private placement of pre-funded and common warrants; pre-funded warrants priced at $0.9499.
- Common warrants exercisable at $1.00/share, expire 5 years after stockholder approval.
- Existing warrants from Nov 2024 amended to reduce exercise price to $1.00 per share.
- Special meeting on Mar 4 lacked quorum; proposals move to 2025 annual meeting set for June 11, 2025.
- Record date for 2025 annual meeting is April 15, 2025; stockholder proposals due by March 17, 2025.

## SEC filing metadata
- accession: 0001493152-25-009571
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2025-03-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 5.07, 8.01, 5.08, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000149315225009571/0001493152-25-009571-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000149315225009571/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-009571
- JSON: https://secwatch.observer/filing/0001493152-25-009571.json
- Plain text: https://secwatch.observer/filing/0001493152-25-009571.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.